IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label Avastin. Show all posts
Showing posts with label Avastin. Show all posts
Saturday, 14 March 2009

Roche and Genentech: The Knot Is Nearly Tied

›
Following my report on Thursday evening regarding the acquisition by Merck of Schering-Plough, let us consider briefly the announcement made...
›
Home
View web version
Powered by Blogger.